| Market Capitalization (Millions $) |
384 |
| Shares
Outstanding (Millions) |
59 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-89 |
| Cash Flow (TTM) (Millions $) |
-70 |
| Capital Exp. (TTM) (Millions $) |
7 |
Freeline Therapeutics Holdings Plc
Freeline Therapeutics Holdings Plc is a gene therapy company focusing on developing unique treatments for patients suffering from genetic diseases. They use a proprietary technology platform to design, construct, and deliver gene therapies directly to target cells within the body. Freeline's mission is to provide one-time transformative treatments that can potentially cure or significantly improve the lives of patients with genetic disorders. The company is headquartered in the United Kingdom and is publicly traded on the London Stock Exchange under the ticker symbol FRLN.
Company Address: Sycamore House Stevenage 0
Company Phone Number: (0)1438 906870 Stock Exchange / Ticker: NASDAQ FRLN
|
0.000%
